The trial, sponsored by Seoul National University Hospital, aims to evaluate the effectiveness of an AI-driven dietary management system in improving dietary behaviors and metabolic health among adults undergoing health screening. This innovative approach positions the asset within the growing digital health and personalized nutrition markets, which are projected to expand significantly due to increasing health awareness and the demand for tailored health solutions. The competitive landscape includes traditional dietary management programs and emerging digital health platforms. Successful outcomes could enhance the sponsor's reputation in the digital health space and attract potential partnerships or investments. However, the trial's not-yet-recruiting status indicates a need for ongoing diligence regarding recruitment timelines and regulatory considerations.